Argent Trust CO Biogen Inc. Transaction History

Argent Trust CO

$2.25 Billion
Q2 2024

A detailed history of Argent Trust CO transactions in Biogen Inc. stock. As of the latest transaction made, Argent Trust CO holds 1,351 shares of BIIB stock, worth $262,918. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,351

Previous 1,392 2.95%

Holding current value

$262,918

Previous $300,000 4.33%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$190.52 - $236.72 $7,811 - $9,705	-41 Reduced 2.95%	1,351 $313,000
Q1 2024 May 10, 2024	BUY	$212.02 - $267.71 $94,136 - $118,863	444 Added 46.84%	1,392 $300,000
Q4 2023 Feb 09, 2024	BUY	$222.59 - $267.94 $13,355 - $16,076	60 Added 6.76%	948 $245,000
Q3 2023 Nov 08, 2023	BUY	$253.3 - $285.89 $224,930 - $253,870	888 New	888 $228,000
Q4 2021 Feb 09, 2022	SELL	$223.92 - $287.77 $225,039 - $289,208	-1,005 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$282.99 - $369.05 $97,631 - $127,322	345 Added 52.27%	1,005 $284,000
Q2 2021 Aug 09, 2021	BUY	$259.0 - $414.71 $170,940 - $273,708	660 New	660 $228,000
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $199,107 - $229,893	-752 Closed	0 $0
Q2 2020 Aug 04, 2020	BUY	$258.66 - $342.55 $8,794 - $11,646	34 Added 4.74%	752 $202,000
Q1 2020 May 11, 2020	BUY	$268.85 - $341.04 $193,034 - $244,866	718 New	718 $227,000
Q2 2019 Aug 13, 2019	SELL	$219.29 - $241.72 $198,018 - $218,273	-903 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $22,321 - $34,912	-103 Reduced 10.24%	903 $213,000
Q4 2018 Feb 06, 2019	BUY	$278.5 - $352.75 $23,672 - $29,983	85 Added 9.23%	1,006 $303,000
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $51,364 - $67,170	175 Added 23.46%	921 $321,000
Q2 2018 Apr 15, 2019	BUY	$257.52 - $306.91 $192,109 - $228,954	746 New	746 $214,000

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $28B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Argent Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Argent Trust CO with notifications on news.

Account